IMAX CEO Richard Gelfond takes medical leave for pneumonia treatment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
IMAX Corporation Announces CEO Richard Gelfond Taking Temporary Medical Leave of Absence
March 30, 2026 4:15 PM EDTNEW YORK--(BUSINESS WIRE)-- IMAX Corporation (NYSE: IMAX) today announced CEO Richard Gelfond is on a temporary medical leave of absence as he undergoes treatment for pneumonia. He is receiving outstanding care and progressing in his recovery.
While he receives medical care and recovers, Mr. Gelfond will not be participating in any public or private events for the Company. Consistent with its operating plan in the event of Mr. Gelfonds temporary absence, the Companys senior executives are executing their day-to-day responsibilities in coordination with each other and Board Chairman Darren... More
